Randomized Phase II trial of paclitaxel plus valproic acid vs paclitaxel alone as second-line therapy for patients with advanced gastric cancer

The standard regimen of second-line chemotherapy for patients with unresectable gastric cancer has not been established. However, weekly paclitaxel (wPTX) has become the preferable second-line chemotherapy in Japan. Histone deacetylase (HDAC) inhibitors have been shown to have antiproliferative acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Fushida, Sachio, Kaji, Masahide, Oyama, Katsunobu, Hirono, Yasuo, Nezuka, Hideaki, Takeda, Toshiya, Tsukada, Tomoya, Fujimoto, Daisuke, Ohyama, Shigekazu, Fujimura, Takashi, Ohta, Tetsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410891/
https://www.ncbi.nlm.nih.gov/pubmed/25960665
http://dx.doi.org/10.2147/OTT.S83114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410891/
https://www.ncbi.nlm.nih.gov/pubmed/25960665
http://dx.doi.org/10.2147/OTT.S83114

Ejemplares similares